CoChat
Sign Up
Cited by 10

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Causality Assessment Methods in Drug-Induced Liver Injury

Teschke, Rolf, Danan, Gaby·2018·Methods in Pharmacology and Toxicology
DOI 10.1007/978-1-4939-7677-5_27
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1007/978-1-4939-7677-5_27

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The DILIN method for causality assessment comes along without any specific element scoring and provides only arbitrary causality gradings as percentage ranges.

    “used the method of the Drug-Induced Liver Injury Network (DILIN)67 for causality assessment, which comes along without any specific element scoring and provides only arbitrary causality gradings as percentage ranges;68”

    From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [68]

  • Other CAMs used in the FDA study are known for being not specific for liver injury cases and not based on typical, individually scored liver-related key elements.

    “additionally, other CAMs were used,67 known for being not specific for liver injury cases and not based on typical, individually scored liver-related key elements, as amply discussed previously15 and reiterated recently.68”

    From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [68]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 168

  1. Sarges P, Steinberg JM, Lewis JH (2016) Drug-induced liver injury: highlights from a review of the 2015 literature. Drug Saf 39:561–575. https://doi.org/10.1007/s4026401604278 · DOI
  2. Chen M, Borlak J, Tong W (2013) High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology 58:388–396 · DOI
  3. Chen M, Borlak J, Tong W (2014) Predicting idiosyncratic drug-induced liver injury—some recent advances. Expert Rev Gastroenterol Hepatol 8:721–723. https://doi.org/10.1586/17474124.922871 · DOI
  4. Teschke R, Andrade RJ (2016) Special issue “Drug, Herb, and Dietary Supplement Hepatotoxicity”. Int J Mol Sci. http://www.mdpi.com/journal/ijms/special_issues/Hepatotoxicity . Last Accessed 15 Dec 1016
  5. Teschke R, Andrade RJ (2016) Editorial: drug, herb, and dietary supplement hepatotoxicity. Int J Mol Sci 17:1488. https://doi.org/10.3390/ijms17091488 · DOI
  6. Danan G, Teschke R (2016) RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci 17:14. https://doi.org/10.3390/ijms17010014 · DOI · Paper page
  7. Hayashi PH (2016) Drug-induced Liver Injury Network causality assessment: criteria and experience in the United States. Int J Mol Sci 17:201. https://doi.org/10.3390/ijms17020201 · DOI
  8. Björnsson ES (2016) Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci 17:224. https://doi.org/10.3390/ijms17020224 · DOI · Paper page
  9. Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ (2016) Case characterization, clinical features and risk factors in drug-induced liver injury. Int J Mol Sci 17:714. https://doi.org/10.3390/ijms17050714 · DOI
  10. Bessone F, Hernandez N, Lucena MI, Andrade RJ, on behalf of the Latin DILI Network (LATINDILIN) and Spanish DILI Registry (2016) The Latin American DILI registry experience: a successful ongoing collaborative strategic initiative. Int J Mol Sci 17:313. https://doi.org/10.3390/ijms17030313 · DOI
  11. Frenzel C, Teschke R (2016) Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci 17:588. https://doi.org/10.3390/ijms17050588 · DOI · Paper page
  12. Valdivia-Correa B, Gómez-Gutiérrez C, Uribe M, Méndez-Sánchez N (2016) Herbal medicine in Mexico: a cause of hepatotoxicity. A critical review. Int J Mol Sci 17:235. https://doi.org/10.3390/ijms17020235 · DOI
  13. Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J (2016) Herb-induced liver injury in the Berlin Case-Control Surveillance Study. Int J Mol Sci 17:114. https://doi.org/10.3390/ijms17010114 · DOI
  14. Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E (2016) Hepatotoxicity induced by “the 3Ks”: Kava, Kratom and Khat. Int J Mol Sci 17:580. https://doi.org/10.3390/ijms17040580 · DOI
  15. Teschke R, Eickhoff A (2016) The Honolulu liver disease cluster at the medical center: its mysteries and challenges. Int J Mol Sci 17:476. https://doi.org/10.3390/ijms17040476 · DOI · Paper page
  16. Avigan MI, Mozersky RP, Seeff LB (2016) Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. Int J Mol Sci 17:331. https://doi.org/10.3390/ijms17030331 · DOI
  17. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36:451–455 · DOI
  18. de Abajo FJ, Montero D, Madurga M, García Rodríguez LA (2004) Acute and clinically relevant drug-induced liver injury: population based case–control study. Br J Clin Pharmacol 58:71–80 · DOI
  19. Danan G, Bénichou C (1993) Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323–1330 · DOI · Paper page
  20. Aithal GP, Rawlins MD, Day CP (1999) Accuracy of hepatic adverse drug reactions reported in one English health region. Br Med J 319:1541 · DOI
  21. Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J (2014) Drug induced liver injury: accuracy of diagnosis in published reports. Ann Hepatol 13:248–255 · DOI
  22. Andrade RJ, Lucena MI, Kaplowitz N, García-Muñoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guaner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R (2006) Outcome of acute idiosyncratic drug-induced liver injury: long term follow-up in a hepatotoxicity registry. Hepatology 44:1581–1588 · DOI · Paper page
  23. Miljkovic MM, Dobric S, Dragojevic-Simic V (2011) Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity. Pharmacoepidemiol Drug Saf 20:272–285 · DOI
  24. Miljkovic MM, Dobric S, Dragojevic-Simic V (2012) Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity. J Clin Pharm Ther 37:196–203 · DOI
  25. Björnsson E, Jacobsen EI, Kalaitzakis E (2012) Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 56:374–380. https://doi.org/10.1016/j.jhep.2011.07.023 · DOI
  26. Bénichou C, Danan G, Flahault A (1993) Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 46:1331–1336 · DOI · Paper page
  27. Teschke R, Danan G (2017) Drug-induced liver injury: is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol 13:425–438. https://doi.org/10.1080/17425255.2017.1252749 · DOI
  28. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiodt FV, Ostapowicz G, Shakil AO, Lee WM, the Acute Liver Failure Study Group (2005) Acetaminophen-induced acute liver failure: results of a United States multicentre, prospective study. Hepatology 42:1364–1372 · DOI
  29. Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J (2015) Features and outcomes of 889 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 148:1340–1352. https://doi.org/10.1053/j.gastro.2015.03.006 · DOI · Paper page
  30. Maria VAJ, Victorino RMM (1997) Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 26:664–669 · DOI · Paper page
  31. Takikawa H, Takamori Y, Kumagi T, Onji M, Watanabe M, Shibuya A, Hisamochi A, Kumashiro R, Ito T, Mitsumoto Y, Nakamura A, Sakaguchi T (2003) Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol Res 27:192–195 · DOI · Paper page
  32. Kaplowitz N (2001) Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology 33:308–310 · DOI
  33. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245 · DOI · Paper page
  34. Teschke R, Frenzel C, Schulze J, Eickhoff A (2013) Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol 19:2864–2882 · DOI
  35. Bénichou C (1990) Criteria of drug-induced liver disorders. Report of an international Consensus meeting. J Hepatol 11:272–276 · DOI · Paper page
  36. Teschke R, Eickhoff A, Schulze J, Wolff A, Frenzel C, Melchart D (2016) Petadolex®, a herbal extract for migraine prophylaxis with spontaneous case reports of disputed liver injury: robust causality evaluation by RUCAM, the Roussel Uclaf Causality Assessment Method. Eur J Pharmaceut Med Res 3(12):154–177
  37. Zimmerman HJ (1999) Hepatotoxicity, 2nd edn. Lippincott Williams & Wilkins, Philadelphia
  38. Safari S, Motavaf M, Siamdoust SAS, Alavian SM (2014) Hepatotoxicity of halogenated inhalation anesthetics. Iran Red Crescent Med J 16(9):e20153 · DOI
  39. Gaude GS, Chaudhury A, Hattiholi J (2015) Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. J Family Med Prim Care 4:238–243. https://doi.org/10.4103/2249-4863.154661 · DOI
  40. Lee SS, Lee CM, Kim TH, Kim JJ, Lee JM, Kim HJ, Ha CY, Kim HJ, Jung WT, Lee OJ, Kim DY (2016) Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 20:800–805. https://doi.org/10.5588/ijtld.15.0668 · DOI
  41. Agarwal VK, McHutchison JG, Hoofnagle JH, Drug-Induced Liver Injury Network (DILIN) (2010) Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol 8:463–470 · DOI
  42. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH, for the Drug-Induced Liver Injury Network (DILIN) (2011) Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 141:1665–1672. https://doi.org/10.1053/j.gastro.2011.07.051 · DOI
  43. Hoofnagle JH, Nelson KE, Purcell RH (2012) Review article: hepatitis E. N Engl J Med 367:1237–1244 · DOI
  44. Teschke R, Schulze J, Eickhoff A, Wolff A, Frenzel C (2015) Review article: mysterious hawaii liver disease case—naproxen overdose as cause rather than OxyELITE Pro? J Liver Clin Res 2:1013. http://www.jscimedcentral.com/Liver/liver-2-1013.pdf . Last accessed 15 Dec 2016
  45. Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A (2016) The mystery of the Hawaii liver disease cluster in summer 2013: a pragmatic and clinical approach to solve the problem. Ann Hepatol 15:91–119. http://www.annalsofhepatology.com.mx/revista/numeros/2016/HP161-12-Mystery%20(web)%20(FF_041215V)_PROTEGIDO%20(1).pdf . Last accessed 15 Dec 2016 · DOI · Paper page
  46. Teschke R, Eickhoff A (2017) Suspected liver injury and the dilemma of causality. Dig Dis Sci 62:1095–1098. https://doi.org/10.1007/s10620-016-4442-5 · DOI
  47. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW, International Autoimmune Hepatitis Group (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176 · DOI · Paper page
  48. Teschke R, Frenzel C (2014) Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today? Ann Hepatol 13:121–126 · DOI
  49. Teschke R, Eickhoff A, Schwarzenboeck A, Schmidt-Taenzer W, Genthner A, Frenzel C, Wolff A, Schulze J (2015) Clinical review: herbal hepatotoxicity and the call for systematic data documentation of individual cases. J Liver Clin Res 2(1):1008. http://www.jscimedcentral.com/Liver/liver-2-1008.pdf . Last accessed 15 December 2016
  50. Teschke R, Danan G (2016) Diagnosis and management of drug-induced liver injury (DILI) in patients with pre-existing liver disease. Drug Saf 39:729–744. https://doi.org/10.1007/s40264-016-0423-z · DOI
  51. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, Gonzalez-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R, Spanish Group for the Study of Drug-induced Liver Disease (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521 · DOI
  52. Wai CT (2016) Presentation of drug-induced liver injury in Singapore. Singapore Med J 47:116–120
  53. Björnsson E, Olsson R (2007) Serious adverse liver reactions associated with herbal weight loss supplements. J Hepatol 47:295–297 · DOI
  54. García-Cortés M, Borraz Y, Lucena MI, Peláez G, Salmerón J, Diago M, Martínez-Sierra MC, Navarro JM, Planas R, Soria MJ, Bruguera M, Andrade RJ (2008) Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 100:688–695 · DOI
  55. García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ (2008) Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 27:780–789 · DOI · Paper page
  56. Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, Graham J, Park BK, Dillon JF, Bernal W, Cordell HJ, Pirmohamed M, Aithal GP, Day CP, for the DILIGEN Study & International SAE Consortium (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41:816–819 · DOI
  57. Jung KA, Min HJ, Yoo SS, Kim HJ, Choi SN, Ha CY, Kim HJ, Kim TH, Jung WT, Lee OJ, Lee JS, Shim SG (2011) Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum Thun. Gut Liver 5:493–499 · DOI · Paper page
  58. Chau TN, Cheung WI, Ngan T, Lin J, Lee KWS, Poon WT, Leung VKS, Mak T, Tse ML, the Hong Kong Herb-Induced Liver Injury Network (HK-HILIN) (2011) Causality assessment of herb-induced liver injury using multidisciplinary approach and the Roussel Uclaf Causality assessment Method (RUCAM). Clin Toxicol 49:34–39 · DOI · Paper page
  59. Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BHC, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe’er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK, Spanish DILI Registry, EUDRAGENE, DILIN, DILIGEN, and International SAEC (2011) Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141:338–347 · DOI
  60. Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E (2014) Flupirtine-induced liver injury—seven cases from the Berlin Case–Control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database. Eur J Clin Pharmacol 70:453–459 · DOI
  61. Robles-Diaz M, Gonzalez-Jimenez A, Medina-Caliz I, Stephens C, García-Cortes M, García-Muñoz B, Ortega-Alonso A, Blanco-Reina E, Gonzalez-Grande R, Jimenez-Perez M, Rendón P, Navarro JM, Gines P, Prieto M, Garcia-Eliz M, Bessone F, Brahm JR, Paraná R, Lucena MI, Andrade RJ, on behalf of the Spanish DILI Registry and the SLatinDILI Network (2015) Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther 41:116–125 · DOI · Paper page
  62. Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Sarganas G, Kreutz R, Garbe E (2015) Drug-induced liver injury: results from the hospital-based Berlin Case–Control Surveillance Study. Br J Clin Pharmacol 79:988–999. https://doi.org/10.1111/bcp.12565 · DOI
  63. Flamenbaum M, Abergel A, Marcato N, Zénut KJL, Cassan P (1998) Regressive fulminant hepatitis, acute pancreatitis and renal insufficiency after taking ketoprofen. Gastroenterol Clin Biol 22:975
  64. Stickel F, Baumüller HM, Seitz K, Vasilakis D, Seitz G, Seitz HK, Schuppan D (2003) Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepatol 39:62–67 · DOI
  65. Masumoto T, Horiike N, Abe M, Kumaki T, Matsubara H, Fazle Akbar SM, Michitaka K, Hyodo I, Onji M (2003) Diagnosis of drug-induced liver injury in Japanese patients by criteria of the Consensus Meetings in Europe. Hepatol Res 25:1–7 · DOI
  66. Andrade RJ, Lucena MI, Alonso A, García-Cortés M, García-Ruiz E, Benitez R, Fernández MC, Pelaez G, Romero M, Corpas R, Durán JA, Jiménez M, Rodrigo L, Nogueras F, Martín-Vivaldi R, Navarro JM, Salmerón J, Sánchez de la Cuesta F, Hidalgo R (2004) HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39:1603–1612 · DOI
  67. Arotcarena R, Bigué JP, Etcharry F, Pariente A (2004) Pioglitazone-induced acute severe hepatitis. Gastroenterol Clin Biol 28:609–618. Abstract in English, article in French · DOI
  68. Lee WM, Larrey D, Olsson R, Lewis JH, Keisu M, Auclert L, Sheth S (2005) Hepatic findings in long-term clinical trials of ximelagatran. Drug Saf 28:351–370 · DOI
  69. Jorge OA, Jorge AD (2005) Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm Dig 97:115–124 · DOI
  70. Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, Salamé E, Piquet MA, Dao T (2005) Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 17:1135–1137 · DOI
  71. Fontana RJ, Shakil O, Greenson JK, Boyd I, Lee WM (2005) Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci 50(10):1785–1790 · DOI
  72. De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E (2006) Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther 24:1187–1195 · DOI
  73. Yuen MF, Tam S, Fung J, Wong DKH, Wong BCY, Lai CL (2006) Traditional Chinese Medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 24:1179–1186 · DOI · Paper page
  74. Cárdenas A, Restrepo JC, Sierra F, Correa G (2006) Acute hepatitis due to shen-min: a herbal product derived from Polygonum multiflorum. J Clin Gastroenterol 40:629–632 · DOI
  75. Yan B, Leung Y, Urbanski SJ, Myers RP (2006) Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs. Can J Gastroenterol 20:351–355 · DOI
  76. Hussaini SH, O’Brien CS, Despott EJ, Dalton HR (2007) Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol 19:15–20 · DOI
  77. Stojanovski SD, Casavant MJ, Mousa HM, Baker P, Nahata MC (2007) Atomoxetine-induced hepatitis in a child. Clin Tox 45:51–55 · DOI
  78. Björnsson E, Kalaitzakis E, Klinteberg VAV, Alem E, Olsson R (2007) Long-term follow-up of patients with mild to moderate drug-induced liver injury. Aliment Pharmacol 26:79–85 · DOI
  79. Rigato I, Cravatari M, Avellini C, Ponte E, Crocè SL, Tiribelli C (2007) Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1. Nat Clin Pract Gastroenterol Hepatol 4:403–408 · DOI
  80. Teschke R, Schwarzenboeck A, Hennermann KH (2008) Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 20:1182–1193 · DOI
  81. Kang SH, Kim JI, Jeong KH, Ko KH, Ko PG, Hwang SW, Kim EM, Kim SH, Lee HY, Lee BS (2008) Clinical characteristics of 159 cases of acute toxic hepatitis. Korean J Hepatol 14:483–492. Abstract in English, article in Korean · DOI
  82. Sohn CH, Cha MI, Oh BJ, Yeo WH, Lee JH, Kim W, Lim KS (2008) Liver transplantation for acute toxic hepatitis due to herbal medicines and preparations. J Korean Soc Clin Toxicol 6:110–116. Abstract in English, article in Korean
  83. Choi GY, Yang HW, Cho SH, Kang DW, Go H, Lee WC, Lee YJ, Jung SH, Kim AN, Cha SW (2008) Drug-induced hepatitis caused by albendazole. J Korean Med Sci 23:903–905 · DOI · Paper page
  84. Teschke R, Bahre R (2009) Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Ann Hepatol 8:258–266 · DOI · Paper page
  85. Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S (2009) Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65:331–341 · DOI
  86. Stickel F, Droz S, Patsenker E, Bögli-Stuber K, Aebi B, Leib SL (2009) Severe hepatotoxicity following ingestion of Herbalife nutritionally supplements contaminated with Bacillus subtilis. J Hepatol 50:111–117 · DOI
  87. Kang HS, Choi HS, Yun TJ, Lee KG, Seo YS, Yeon JE, Byun KS, Um SH, Kim CD, Ryu HS (2009) A case of acute cholestatic hepatitis induced by Corydalis speciosa Max. Korean J Hepatol 15:517–523. Abstract in English, article in Korean · DOI · Paper page
  88. Teschke R, Schwarzenboeck A (2009) Suspected hepatotoxicity by cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine 16:72–84 · DOI
  89. Teschke R, Bahre R, Fuchs J, Wolff A (2009) Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases. Menopause 16:956–965 · DOI
  90. Kim SY, Yim HJ, Ahn JH, Kim JH, Kim JN, Yoon I, Kim DI, Lee HS, Lee SW, Choi JH (2009) Two cases of toxic hepatitis caused by arrowroot juice. Korean J Hepatol 15:504–509. Abstract in English, article in Korean · DOI
  91. Harugeri A, Parthasarathi G, Sharma J, D’Souza GA, Ramesh M (2009) Montelukast induced acute hepatocellular injury. J Postgrad Med 55:141–142 · DOI
  92. Licata A, Calvaruso V, Capello M, Craxi A, Almasio PL (2010) Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication. Dig Liver Dis 42:143–148 · DOI
  93. Essaid A, Timraz A (2010) Cholestatic acute hepatitis induced by tadalafil (Cialis®). Gastroenterol Clin Biol 34:e1–e2. Abstract in English, article in French · DOI
  94. Jóhannsson M, Ormarsdóttir S, Olafsson S (2010) Hepatotoxicity associated with the use of Herbalife. Laeknabladid 96:167–172 · DOI
  95. Bae SH, Kim DH, Bae YS, Lee KJ, Kim DW, Yoon JB, Hong JH, Kim SH (2010) Toxic hepatitis associated with Polygoni multiflori. Korean J Hepatol 16:182–186. Abstract in English, article in Korean · DOI · Paper page
  96. Treeprasertsuk S, Huntrakul J, Ridtitid W, Kullavanijaya P, Björnsson ES (2010) The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents. Aliment Pharmacol Ther 11:1200–1207 · DOI
  97. Yang HN, Kim DJ, Kim YM, Kim BH, Sohn KM, Choi MJ, Choi YH (2010) Aloe-induced toxic hepatitis. J Korean Med Sci 25:492–495 · DOI · Paper page
  98. Singla A, Hammad HT, Hammoud GM (2010) Uncommon cause of acute drug-induced liver injury following mammoplasty. Gastroenterol Res 3:171–172
  99. Teschke R (2010) Kava hepatotoxicity: a clinical review. Ann Hepatol 9:251–265 · DOI
  100. Lin G, Wang JY, Li N, Li M, Gao H, Ji Y, Zhang F, Wang H, Zhou Y, Ye Y, Xu HX, Zheng J (2011) Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 54:666–673 · DOI · Paper page
  101. Gluck N, Fried M, Porat R (2011) Acute amiodarone liver toxicity likely due to ischemic hepatitis. Isr Med Ass J 13:748–752
  102. Sabaté M, Ibáñez L, Pérez E, Vidal X, Buti M, Xiol X, Mas A, Guarner C, Forné M, Solà R, Castellote J, Rigau J, Laporte JR (2011) Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterol 11:80. http://www.biomedcentral.com/1471-230X/11/80 . Last accessed 15 December 2016 · DOI
  103. Teschke R, Glass X, Schulze J (2011) Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol 61:282–291 · DOI
  104. Teschke R, Schmidt-Taenzer W, Wolff A (2011) Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol Drug Saf 20:567–582 · DOI
  105. Teschke R, Frenzel C, Schulze J, Eickhoff A (2012) Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 63:1–9 · DOI
  106. Timcheh-Hariri A, Balali-Mood M, Aryan E, Sadeghi M, Riahi-Zanjani B (2012) Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. Food Chem Toxicol 50:3826–3832 · DOI
  107. Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A (2012) Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol 11:838–848 · DOI
  108. Moch C, Rocher F, Lainé P, Lacotte J, Biour M, Gouraud A, Bernard N, Descotes J, Vial T (2012) Etifoxine-induced acute hepatitis: a case series. Clin Res Gastroenterol Hepatol 36:e85–e88 · DOI
  109. Kim YJ, Ryu SL, Shim JW, Kim DS, Shim JY, Park MS, Jung HL (2012) A pediatric case of toxic hepatitis induced by Hovenia dulcis. Pediatr Gastroenterol Hepatol Nutr 15:111–116 · DOI
  110. Gao H, Li N, Wang JY, Zhang SC, Lin G (2012) Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis 13:33–39 · DOI · Paper page
  111. Sprague D, Bamha K (2012) Drug-induced liver injury due to varenicline. BMC Gastroenterol 12:65 · DOI
  112. Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, Baik GH, Kim JB, Kweon YO, Kim BI, Kim SH, Kim IH, Kim JH, Nam SW, Paik YH, Suh JI, Sohn JH, Ahn BM, Um SH, Lee HJ, Cho M, Jang MK, Choi SK, Hwang SG, Sung HT, Choi JY, Han KH (2012) A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 107:1380–1387 · DOI
  113. Hou FQ, Zeng Z, Wang GQ (2012) Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes. Cell Biochem Biophys 64:77–83 · DOI
  114. Nabha L, Balba GP, Tuanzon C, Kumar PN (2012) Etravirine induced severe hpersensitivity reaction and fulminant hepatitis: a case report and review of the literature. J AIDS Clin Res S2:005. https://doi.org/10.4172/2155-6113.S2-005 · DOI
  115. Teschke R, Frenzel C, Wolff A, Herzog J, Glass X, Schulze J, Eickhoff A (2012) Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvements. Ann Hepatol 11:500–512 · DOI
  116. Ripault MP, Pinzani V, Fayolle V, Pageaux GP, Larrey D (2013) Crizotinib-induced acute hepatitis: first case with relapse after reintroduction with reduced dose. Clin Res Gastroenterol Hepatol 37:e21–e23 · DOI
  117. Carrier P, Godet B, Crepin S, Magy L, Debette-Gratien M, Pillegand B, Jacques J, Sautereau D, Vidal E, Labrousse F, Gondran G, Loustaud-Ratti V (2013) Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity. Clin Res Gastroenterol Hepatol 37:100–104 · DOI
  118. Ríos D, Restrepo JC (2013) Abendazole-induced liver injury: a case report. Colombia Méd 44:118–120 · DOI
  119. Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A (2013) Herbalife hepatotoxicity: evaluation of cases with positive reexposure tests. World J Hepatol 5:353–363 · DOI
  120. Goossens N, Spahr L, Rubbia-Brandt L (2013) Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report. J Hepatol 59:1139–1142 · DOI
  121. Markova SM, De Marco T, Bendjilali N, Kobashigawa EA, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie AE, Khojasteh C, McGlothlin D, AHB W, Hsueh WC, Witte JS, Schwartz JB, Kroetz DL (2013) Association of CYP2C9*2 with bosentan-induced liver injury. Clin Pharmacol Ther 94:678–686 · DOI
  122. Abenavoli L, Milic N, Beaugrand M (2013) Severe hepatitis by cyproterone acetate: role of corticosteroids. A case report. Ann Hepatol 12:152–155 · DOI
  123. Marumoto A, Roytman MM, Tsai NCS (2013) Trial and error: investigational drug induced liver injury, a case series report. Hawaii J Med Publ Health 72(Suppl 4):30–33
  124. Adnan MM, Khan M, Hashmi S, Hamza M, AbdulMujeeb S, Amer S (2014) Black cohosh and liver toxicity: is there a relationship? Case Rep Gastrointest Med 2014:860614. https://doi.org/10.1155/2014/860614 · DOI
  125. Lin J, Moore D, Hockey B, Di Lernia R, Gorelik A, Liew D, Nicoll A (2014) Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in traumatic patients. Liver Int 34:576–586 · DOI
  126. Cheetham TC, Lee J, Hunt CM, Niu F, Reisinger S, Murray R, Powell G, Papay J (2014) An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data. Pharmacoepidemiol Drug Saf 23:601–608 · DOI
  127. Russmann S, Niedrig DF, Budmiger M, Schmidt C, Stieger B, Hürlimann S, Kullak-Ublick GA (2014) Rivaroxaban postmarketing risk of liver injury. J Hepatol 61:293–300 · DOI
  128. Bohm N, Bohm N, Makowski C, Machado M, Davie A, Seabrook N, Wheless L, Bevill B, Clark B, Kyle TR III (2014) Case report and cohort analysis of drug-induced liver injury associated with daptomycin. Antimicrob Agents Chemother 58:4902–4903 · DOI
  129. Saiful-Islam M, Wright G, Tanner P, Lucas R (2014) A case of anastrazole-related drug-induced autoimmune hepatitis. Clin J Gastroenterol 7:414–417 · DOI
  130. Im SG, Yoo SH, Jeon DO, Cho HJ, Choi JY, Paik S, Park YM (2014) Chelidonium majus-induced acute hepatitis. Ewha Med J 37:60–63 · DOI
  131. Lim R, Choundry H, Conner K, Karnsakul W (2014) A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug? Case Rep Pediatr 2014:156389
  132. Veluswamy RR, Ward SC, Yum K, Abramovitz RB, Isola LM, Jagannath S, Parekh S (2014) Adverse drug reaction: pomalidomide-induced liver injury. Lancet 383:2125–2126 · DOI
  133. Teschke R, Zhang L, Melzer L, Schulze J, Eickhoff A (2014) Green tea extract and the risk of drug-induced liver injury. Expert Opin Drug Metab Toxicol 10:1663–1676. https://doi.org/10.1517/17425255.2014.971011 · DOI
  134. Pillukat MH, Bester C, Hensel A, Lechtenberg M, Petereit F, Beckebaum S, Müller KM, Schmidt HHJ (2014) Concentrated green tea extract induces severe acute hepatitis in a 63-year-old woman—a case report with pharmaceutical analyis. J Ethnopharmacol 155:165–170. https://doi.org/10.1016/j.jep.2014.05.015 · DOI
  135. Lee WJ, Kim HW, Son CG (2015) Systematic review on herb induced liver injury in Korea. Food Chem Toxicol 84:47–54. https://doi.org/10.1016/j.fct.2015.06.004 · DOI · Paper page
  136. Yilmaz B, Yilmaz B, Aktaş B, Unlu O, Roach EC (2015) Lesser celandine (pilewort) induced acute toxic liver injury: the first case report worldwide. World J Hepatol 7:285–288 · DOI
  137. Mazzanti G, Di Soto A, Vitalone A (2015) Hepatotoxicity of green tea: an update. Arch Toxicol 89:1175–1191 · DOI · Paper page
  138. Tauqeer A, Pandey R, Shah R, Black J (2015) Resolution of ipilimumab induced severe hepatotoxicity with triple immunosuppressants therapy. BMJ Case Rep. https://doi.org/10.1136/bcr-2014-208102 . Last accessed 15 Dec 2016 · DOI
  139. Son CG (2015) Drug-induced liver injury by Western medication. J Int Korean Med 36:69–75 · DOI
  140. Baig M, Wool KJ, Halalnych JH, Sarmad RA (2015) Acute liver failure after initiation of rivaroxaban: a case report and review of the literature. N Am J Med Sci 7:407–410 · DOI
  141. Tang DM, Koh C, Twaddell WS, von Rosenvinge EC, Han H (2015) Acute hepatocellular drug-induced liver injury from bupropion and doxycycline. ACG Case Rep J 3:66–68 · DOI
  142. Zambrone FAD, Corrêa CL, Sampaio do Amaral LM (2015) A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife products. Braz J Pharm Sci 51. https://doi.org/10.1590/S1984-82502015000400004 · DOI
  143. Woo HJ, Kim HY, Choi ES, Cho Y, Kim Y, Lee JH, Jang E (2015) Drug-induced liver injury: a 2-year retrospective study of 1169 hospitalized patients in a single medical center. Phytomedicine 13:1201–1205. http://www.sciencedirect.com/science/article/pii/S0944711315003049 · DOI
  144. Wang J, Ma Z, Niu M, Zhu Y, Liang Q, Zhao Y, Song J, Bai Z, Zhang Y, Zhang P, Li N, Meng Y, Li Q, Qin L, Teng G, Cao J, Li B, Chen S, Li Y, Zou Z, Zhou H, Xiao X (2015) Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front Med 9:457–467. https://doi.org/10.1007/s11684-015-0417-8 · DOI
  145. Zhu Y, Li YG, Wang JB, Liu SH, Wang LF, Zhao YL, Bai YF, Wang ZX, Li JY, Xiao XH (2015) Causes, features, and outcomes of drug-induced liver injury in 69 children from China. Gut Liver 9:525–533. https://doi.org/10.5009/gnl14184 · DOI
  146. Zhu Y, Liu SH, Wang JB, Song HB, Li YG, He TT, Ma X, Wang ZX, Wang LP, Zhou K, Bai YF, Zou ZS, Xiao XH (2015) Clinical analysis of drug-induced liver injury caused by Polygonum multiflorum and its preparations. Zhongguo Zhong Xi Yi Jie He Za Zhi 35:1442–1447. (Abstract in English, article in Chinese)
  147. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, Wang RL, He TT, Song HB, Wang ZX, SB P, Ma X, Wang LF, Bai ZF, Zhao YL, Li YG, Wang JB, Xiao XB (2016) Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol 31:1476–1482. https://doi.org/10.1111/jgh.13323. · DOI · Paper page
  148. Papafragkakis C, Ona MA, Reddy A, Anand S (2016) Acute hepatitis after ingestion of a preparation of Chinese Skullcap and Black Catechu for joint pain. Case Rep Hepatol 2016:4356749. https://doi.org/10.1155/2016/4356749 · DOI
  149. Zhang P, Ye Y, Yang X, Jiao Y (2016) Systematic review on Chinese herbal medicine induced liver injury. Evid-Based Complement Alternat Med 2016, 3560812. DOI: https://doi.org/10.1155/2016/3560812 · DOI
  150. Melchart D, Hager S, Dai J, Weidenhammer W (2016) Quality control and complication screening programme of Chinese medicinal drugs at the first German hospital of Traditional Chinese Medicine—a retrospective analysis. Forsch Komplementmed 23:21–28. https://doi.org/10.1159/000444983 · DOI
  151. Dyson JK, Hutchinson J, Harrison L, Rotimi O, Tiniakos D, Foster GR, Aldersley MA, McPherson S (2016) Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use. J Hepatol 64:234–238 · DOI
  152. Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla Y (2017) Acute liver failiure due to Etodolac, a selective cycloxygenase-2 (COX-2) inhibitor non-steroidal anti-inflammatory drug established by RUCAM-based causality assessment. Ann Hepatol 16(5):818–821 · DOI
  153. Ferrajolo C, Verhamme KMC, Trifirò G, ‘t Jong GW, Picelli G, Giaquinto C, Mazzaglia G, Stricker BH, Rossi F, Capuano A, Sturkenboom MC (2017) Antibiotic-induced liver injury in pediatric outpatients: a case-control study in primary care databases. Drug Saf 40(4):305–315 · DOI
  154. García-Cortés M, Stephens C, Lucena MI, Fernández-Castañer A, Andrade RJ, on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease (2011) Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 55:683–669 · DOI · Paper page
  155. Takikawa H (2010) Recent status of drug-induced liver injury and its problems in Japan. Jap Med Ass J 53:243–247
  156. Teschke R, Eickhoff A, Schulze J (2013) Drug and herb induced liver injury in clinical and translational hepatology: causality assessment methods, quo vadis? J Clin Translat Hepatol 1:59–74
  157. Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J, for the DILIN Study Group (2009) Drug-induced liver injury Network (DILIN) prospective study. Rationale, design and conduct. Drug Saf 32:55–68 · DOI · Paper page
  158. Tajiri K, Shimizu Y (2008) Practical guideline for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 14:6774–6785 · DOI
  159. Teschke R, Wolff A (2011) Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Regul Toxicol Pharmacol 59:1–7 · DOI
  160. Liss G, Lewis JH (2009) Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol 5:843–860. https://doi.org/10.1517/17425250903018904 · DOI
  161. Teschke R, Schulze J (2012) Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia. Drug Saf 35:1091–1097 · DOI
  162. Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Wolff A, Hennermann KH (2011) Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol 11:249–259 · DOI
  163. Teschke R, Schmidt-Taenzer W, Wolff A (2012) USP suspected herbal hepatotoxicity: quality of causality assessment is more important than quantity of counted cases, not vice versa. Pharmacoepidemiol Drug Saf 21:336–338 · DOI
  164. Mahady GB, Low Dog T, Barrett ML, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro GI, Sarma DN (2008) United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15:628–638 · DOI
  165. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Low Dog T (2008) Safety of green tea extract: a systematic review by the US Pharmacopeia. Drug Saf 31:469–484 · DOI
  166. WHO (World Health Organization) (2007) Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services, Geneva, Switzerland
  167. Teschke R, Eickhoff A, Wolff A, Frenzel C, Schulze J (2013) Herbal hepatotoxicity and WHO global introspection method. Ann Hepatol 12:11–21 · DOI
  168. Teschke R, Andrade R (2015) Editorial. Drug-induced liver injury: expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment. Gastroenterology 148:1271–1273. https://doi.org/10.1053/j.gastro.2015.04.027. · DOI

Cited by

Sorted by citations

Metadata

Authors
Teschke, R., & Danan, G.
Venue
Methods in Pharmacology and Toxicology
Publisher
Springer New York
Published
2018
Pages
555-594
ISSN
  • 1557-2153
  • 1940-6053
DOI
10.1007/978-1-4939-7677-5_27
Cited by
10
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review